A retrospective study to describe the incidence of moderate to severe allergic reactions to factor IX in subjects with haemophilia B

Haemophilia

Volumn 17, Issue 3, 2011, Pages 494-499

  Recht, M ^a   Pollmann, H ^b   Tagliaferri, A ^c   Musso, R ^d   Janco, R ^e   Richey Neuman, W ^e  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b Hemophilia Center and Institute for Thrombosis and Hemostasis   (Germany)

^c UNIVERSITY HOSPITAL OF PARMA   (Italy)

^d UNIVERSITY OF CATANIA   (Italy)

^e PFIZER INC   (United States)

Author keywords

Allergic reactions; Haemophilia; Inhibitors; PdFIX; RFIX

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 9;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; DISEASE SEVERITY; DRUG EFFECT; DRUG HYPERSENSITIVITY; FEMALE; HEMOPHILIA B; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIDE EFFECT; SYMPTOM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD COAGULATION FACTOR INHIBITORS; CHILD; CHILD, PRESCHOOL; EUROPE; FACTOR IX; FEMALE; HEMOPHILIA B; HUMANS; HYPERSENSITIVITY, IMMEDIATE; INCIDENCE; MALE; MIDDLE AGED; NORTH AMERICA; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 79955139784     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2011.02436.x     Document Type: Article

References (9)

1. National Hemophilia Foundation. Hemophilia B (Factor IX). Available at: Accessed March, 2008.
2. Key NS, Negrier C. Coagulation factor concentrates: past, present, and future. Lancet 2007; 370: 439-48.
3. Warrier I, Ewenstein BM, Koerper MA et al. Factor IX inhibitors and anaphylaxis in hemophilia B. J Pediatr Hematol Oncol 1997; 19: 23-7.
4. Jadhav M, Warrier I. Anaphylaxis in patients with hemophilia. Semin Thromb Hemost 2000; 26: 205-8.
5. Oldenburg J, Pavlova A. Genetic risk factors for inhibitors to factors VIII and IX. Haemophilia 2006; 12(Suppl. 6): 15-22.
6. Sawamoto Y, Shima M, Yamamoto M et al. Measurement of anti-factor IX IgG subclasses in haemophilia B patients who developed inhibitors with episodes of allergic reactions to factor IX concentrates. Thromb Res 1996; 83: 279-86.
7. Warrier I. Inhibitors in hemophilia B. In: Lee CA, Berntorp EE, Hoots WK eds. Textbook of Hemophilia. Oxford: Blackwell Publishing Ltd, 2005: 97-100.
8. DiMichele D. Inhibitor development in haemophilia B: an orphan disease in need of attention. Br J Haematol 2007; 138: 305-15.
9. Thorland EC, Drost JB, Lusher JM et al. Anaphylactic response to factor IX replacement therapy in haemophilia B patients: complete gene deletions confer the highest risk. Haemophilia 1999; 5: 101-5.